Project Details
| Status | Active |
|---|---|
| Effective start/end date | 11/27/19 → 11/30/24 |
Funding
- Quintiles, Inc. (Prot: 254PD101)
- Biogen MA Inc. (Prot: 254PD101)
Prot: 254PD101- A Phase 1 Single- and Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB094 Administered Intrathecally to Adults With Parkinson’s Disease
- Simuni, Tatyana (PD/PI)
Project: Research project